Moreover, the expression level of IGF2BP3 was significantly related to the N stage and lymph node metastasis, suggesting that IGF2BP3 was intimately related to the malignancy progression and clinical features. Here, IGF2BP3 is linked to metastatic malignant neoplasm in the lymph nodes.